Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-07-25
2006-07-25
Goldberg, Jeanine A. (Department: 1634)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C435S320100, C435S200000, C435S069100, C536S023100, C536S023700
Reexamination Certificate
active
07081245
ABSTRACT:
The present invention provides nucleic acids, proteins and vectors for a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain ofChlamydia,specificallyC. pneumoniae.The method employs a vector containing a nucleotide sequence encoding an ATP-binding cassette of a strain ofChlamydia pneumoniaeand a promoter to effect expression of the ATP-binding cassette gene product in the host. Modifications are possible within the scope of this invention.
REFERENCES:
patent: 5474796 (1995-12-01), Brennan
patent: 6403101 (2002-06-01), Murdin et al.
patent: 6559294 (2003-05-01), Griffais et al.
patent: 6822071 (2004-11-01), Stephens et al.
patent: 2004/0005667 (2004-01-01), Ratti et al.
patent: WO 99/27105 (1999-06-01), None
patent: WO 02/02606 (2002-02-01), None
Grayston et al. (1995)Journal of Infectious Diseases168:1231.
Campos et al. (1995)Investigation of Ophthalmology and Visual Science36:1477.
Grayston et al. (1990) Journal of Infectious Diseases 161:618.
Marrie (1993)Clinical Infectious Diseases18:501.
Wang et al. (1986) Chlamydial infections, Cambridge University Press, Cambridge. p. 329.
Saikku et al. (1988)Lancet; ii:983.
Thom et al. (1992)JAMA268:68.
Linnanmaki et al. (1993),Circulation87:1130.
Saikku et al. (1992)Annals Internal Medicine116:273.
Melnick et al. (1993)American Journal of Medicine95:499.
Shor et al. (1992)South African. Medical Journal82:158.
Kuo et al. (1993)Journal of Infectious Diseases167:841.
Kuo et al. (1993)Arteriosclerosis and Thrombosis13:1501.
Campbell et al. (1995)Journal of Infectious Diseases172:585.
Chiu et al. (1997)Circulation96 (7) :2144-2148.
Ramirez et al. (1996)Annals of Internal Medicine125:979.
Jackson et al. Abst. K121, p272, 36th ICAAC, Sep. 15-18, 1996, New Orleans.
Fong et al. (1997)Journal of Clinical Microbiolology35:48.
Hahn et al., “Evidence forChlamydia pneumoniaeinfection in steroid-dependent asthma,”Ann Allergy Asthma Immunol. Jan. 1998; 80(1):45-49.
Hahn et al., “Association ofChlamydia pneumoniaeIgA antibodies with recently symptomatic asthma,”Epidemiol Infect. Dec. 1996; 117(3):513-517.
Bjornsson et al., “Serology of chlamydia in relation to asthma and bronchial hyperresponsiveness,”Scand J Infect Dis. 1996; 28(1): 63-69.
Hahn, “Treatment ofChlamydia pneumoniaeinfection in adult asthma: a before-after trial,” J Fam Pract. Oct. 1995; 41(4): 345-351.
Allegra et al., “Acute exacerbations of asthma in adults,” role ofChlamydia pneumoniae infection, Eur Respit J. Dec. 1994; 7 (12) : 2165-2168.
Hahn et al., “Association ofChlamydia pneumoniae(strain TWAR) infection with wheezing, asthmatic bronchitis, and adultonset asthma,”JAMA. Jul. 10, 1991; 266(2): 225-230.
Pal et al., (1996)Infection and Immunity. 64:5341.
Jones et al. (1995)Vaccine13:715.
Igietseme et al. (1993)Regional Immunology5:317.
Magee et al. (1993)Regional Immunology5:305.
Landers et al. (1991)Infection&Immunity59:3774.
Magee et al. (1995)Infection&Immunity63:516.
Cotter et al. (1995)Infection and Immunity63:4704.
Campbell et al (1990)Infection and Immunity58:93.
McCafferty et al. (1995)Infection and Immunity63:2387-9.
Gaydos et al.; “Similarity ofChlamydia pneumoniaestrains in the Variable Domain IV Region of the Major Outer Membrane Protein Gene,”Infection and Immunity; 60(12):5319-5323, Dec. 1992.
Wiedmann-A1-Ahmad M, et al. “Reactions of polyclonal and neutralizing anti-p54 monoclonal antibodies with an isolated, species-specific 54-kilodalton protein ofChlamydia pneumoniae,” Clin Diagn Lab Immunol. 1997, (6:700-704).
Hughes et al., 1992.Infect. Immun. 60 (9) :3497.
Dion et al., 1990.Virology179:474-477.
Snijders et al., 1991.J. Gen. Virol. 72:557-565.
Langeveld et al.,Vaccine12 (15) :1473-1480, 1994.
Kunkel et al.,Proc. Natl. Acad. Sci. USA (1985) 82:488.
Casey & Davidson,Nucl. Acid Res. (1977) 4:1539.
Cagnon et al.,Protein Engineering(1991) 4(7):843.
Takase et al.,J. Bact. (1987) 169:5692.
Perez Melgosa et al.,Infect Immun(1994) 62:880.
Watson et al.,Nucleic Acids Res(1990) 18:5299.
Watson et al.,Microbiology(1995) 141:2489.
Melgosa et al.,FEMS Microbiol Lett(1993) 112 :199.
Campbell et al.,J Clin Microbiol(1990) 28 :1261.
Iijima et al.,J Clin Microbiol(1994) 32:583.
Http://chlamydia-www.berkeley.edu:4231/.
Bachmaier et al.,Science(1999) 283:1335.
Ausubel et al.; “Current Protocols in Molecular Biology,” John Wiley & Sons Inc.; vol. 1; 1993; 15 sheets.
Silhavy et al., “Experiments with Gene Fusions,”Cold Spring Harbor Laboratory Press; 1984; pp. 191-195.
Davis et al., “A Manual for Genetic Engineering: Advanced Bacterial Genetics”Cold Spring Harbor Laboratory Press; 1980; pp. 174-176.
Jackson et al., “Isolation ofChlamydia pneumoniaefrom a Carotid Endarterectomy Specimen”The Journal of Infectious Diseases(1997) 176:292-295.
Laitinen et al., “Chlamydia pneumoniaeInfection Induces Inflammatory Changes in the Aorta of Rabbits”Infection and Immunity, Nov. 1997, vol. 65, No. 11, pp. 4832-4835.
Rottenberg et al., “Role of Innate and Adaptive Immunity in the Outcome of Primary Infection withChlamydia pneumoniae, as Analyzed in Genetically Modified Mice,”The Journal of Immunology(1999), 162:2829-2836.
Penttila et al., “Depletion of CD8* cells abolishes memory in acquired immunity againstChlamydia pneumoniaein BALB/c mice”Immunology(1999) 97:490-496.
Knudsen et al., “Identification of Two Novel Genes Encoding 97- to 99-Kilodalton Outer Membrane Proteins ofChlamydia pneumoniae” Infection and Immunity, Jan. 1999, vol. 67, No. 1, pp. 375-383.
Parker et al., “Peptide Binding to MHC Class I Molecules: Implications for Antigenic Peptide Prediction”Immunol Res(1995) 14:34-57.
Kalman, S. et al., “Comparative Genomes ofChlamydia peneumoniaeandC. trachomatis,” Nature Genetics(Apr. 1999), vol. 21, No. 4, pp. 385-389, XP000856693.
Kalman et al., “Chlamydia pneumoniaesection 22 of 103 of the complete genome,” retrieved fromChlamydophila pneumoniaeCWL029; EMBL, Heidelberg, FRG Mar. 15, 1999; database accession No. AE001606; XP002191845.
Kalman et al., “Oligopeptide binding protein OPPA—1 or CPN0195 or CP0572”, retrieved fromChlamydophila pneumoniaedatabase accession No. Q9Z8Y9; XP00219846.
Puolakkainen & Makela, “Vaccination against infections byChlamydia pneumoniae,” Comptes Rendus des Seances de L-Academie des Sciences Serie III(Nov. 1999), vol. 322, No. 11, pp. 973-978.
Svanholm et al., “Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion,”J. Immunol. Methods(Aug. 1999), vol. 228, No. 1-2, pp. 121-130, XP000881871.
Svanholm et al., “Protective DNA immunization againstChlamydia pneumoniae,” Scandinavian Journal of Immunology(Apr. 2000), vol. 51, No. 4, pp. 345-353, XP002191683.
Murdin et al., “Use of a mouse lung challenge model to identify antigens protective againstChlamydia pneumoniaelung infection,”J. Infectious Diseases(Jun. 2000), vol. 181, No. suppl. 3, pp. S544-S551, XP000997839.
Wishart et al., “SEQSEE: a comprehensive program suite for protein sequence analysis” (1994)CABIOSvol. 10, No. 2, pp. 121-132.
Dunn Pamela
Murdin Andrew D.
Oomen Raymond P.
Wang Joe
Foley & Lardner LLP
Goldberg Jeanine A.
Sanofi Pasteur Limited
LandOfFree
Chlamydia antigens and corresponding DNA fragments and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chlamydia antigens and corresponding DNA fragments and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlamydia antigens and corresponding DNA fragments and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3567572